Search research articles
Contact Us
Filters
Showing results (101-110 of 179) with videos related to
Page
of 18
Sort By:
Frontiers in Oncology
|
February 20, 2026
Genomic analysis in chemotherapy-naïve prostate cancer prior to PSMA-targeted treatment
Mariam Amghar, Mareike Roscher, Tobias Rausch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 9, 2016
225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Clemens Kratochwil, Frank Bruchertseifer, Frederik L Giesel, et al.
Cancer Biology & Therapy
|
April 1, 2006
Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model
Syed M Abbas Rizvi, Yong Li, Emma Yan Jun Song, et al.
Inorganic Chemistry
|
May 28, 2010
Synthesis of bimetallic uranium and neptunium complexes of a binucleating macrocycle and determination of the solid-state structure by magnetic analysis
Polly L Arnold, Natalie A Potter, Nicola Magnani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 27, 2021
Dosing <sup>225</sup>Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity
Clemens Kratochwil, Leonidas Apostolidis, Hendrik Rathke, et al.
Nuclear Medicine and Biology
|
November 23, 2024
In vitro and in vivo study of <sup>221</sup>Fr and <sup>213</sup>Bi progeny release from the <sup>225</sup>Ac-labelled TiO<sub>2</sub> nanoparticles
Michal Sakmár, Ján Kozempel, Jan Kučka, et al.
Clinical & Experimental Metastasis
|
February 14, 2006
Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer
Chang F Qu, Emma Y Song, Yong Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 4, 2019
Development and dosimetry of <sup>203</sup>Pb/<sup>212</sup>Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?
José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Physics in Medicine and Biology
|
January 11, 2008
The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy
Emma Y Song, Syed M A Rizvi, Chang F Qu, et al.
EJNMMI Research
|
January 22, 2016
Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate
Ho Sze Chan, Mark W Konijnenberg, Erik de Blois, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 179) with videos related to
Sort By:
Page
of 18
Frontiers in Oncology
|
February 20, 2026
Genomic analysis in chemotherapy-naïve prostate cancer prior to PSMA-targeted treatment
Mariam Amghar, Mareike Roscher, Tobias Rausch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 9, 2016
225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Clemens Kratochwil, Frank Bruchertseifer, Frederik L Giesel, et al.
Cancer Biology & Therapy
|
April 1, 2006
Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model
Syed M Abbas Rizvi, Yong Li, Emma Yan Jun Song, et al.
Inorganic Chemistry
|
May 28, 2010
Synthesis of bimetallic uranium and neptunium complexes of a binucleating macrocycle and determination of the solid-state structure by magnetic analysis
Polly L Arnold, Natalie A Potter, Nicola Magnani, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 27, 2021
Dosing <sup>225</sup>Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity
Clemens Kratochwil, Leonidas Apostolidis, Hendrik Rathke, et al.
Nuclear Medicine and Biology
|
November 23, 2024
In vitro and in vivo study of <sup>221</sup>Fr and <sup>213</sup>Bi progeny release from the <sup>225</sup>Ac-labelled TiO<sub>2</sub> nanoparticles
Michal Sakmár, Ján Kozempel, Jan Kučka, et al.
Clinical & Experimental Metastasis
|
February 14, 2006
Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer
Chang F Qu, Emma Y Song, Yong Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 4, 2019
Development and dosimetry of <sup>203</sup>Pb/<sup>212</sup>Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?
José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Physics in Medicine and Biology
|
January 11, 2008
The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy
Emma Y Song, Syed M A Rizvi, Chang F Qu, et al.
EJNMMI Research
|
January 22, 2016
Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate
Ho Sze Chan, Mark W Konijnenberg, Erik de Blois, et al.
Page
of 18